Skip to main content
Neurology® Neuroimmunology & Neuroinflammation logoLink to Neurology® Neuroimmunology & Neuroinflammation
. 2020 Apr 15;7(4):e733. doi: 10.1212/NXI.0000000000000733

Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment

PMCID: PMC7188474  PMID: 32295823

In the article “Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment” by Muñoz-Lopetegi et al.,1 published online March 2, 2020, the y-axis label for figure 5’s right graph should be “CSF anti-GAD65 concentration (IU/mL).” The editorial office regrets the error.

Reference

  • 1.Muñoz-Lopetegi A, de Bruijn MAAM, Boukhrissi S, et al. . Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment. Neurol Neuroimmunol Neuroinflamm 2020;7:e696. doi: 10.1212/NXI.0000000000000696. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Neurology® Neuroimmunology & Neuroinflammation are provided here courtesy of American Academy of Neurology

RESOURCES